Compliance & Legal
Opponents say that if the law takes effect, patients could end up waiting hours or days for price estimates before getting services such as X-rays.
It's the largest ever criminal fine levied against a pharmaceutical company for FCPA violations.
2016 was a busy year when it came to big-dollar settlements, fines and legal wrangling.
The ongoing Attorneys General investigation began in 2014, according to the complaint, and has "uncovered evidence of a broad, well-coordinated and long-running series of schemes."
FPMC billed patients' insurance plans and programs well over half a billion dollars and collected over $200 million in paid claims.
The Tokyo executives declined to answer questions about the correspondence during two days of depositions Nov. 30 and Dec. 1.
Aetna and Humana a good match, CEO tells judge, with company CEOs on much better terms than the leaders of Anthem and Cigna.
HFMA identified a number of different policy proposals and ranked them in terms of probability and positive or negative financial impact.
A massive lobbying effort by 58 pharmaceutical companies, 24 device companies and 26 "biotech products and research" companies shaped the bill.
Providers have been waiting years for payments, applications for benefits have been stalled up to a year, lead attorney says.